Astellas Pharma Europe has announced that Yukio Matsui has been appointed as President of EMEA Operations.
Mr Matsui will take up his post on 1 April and will have responsibility for the company’s commercial operations in Europe, the Middle East and Africa.
He has served as Senior Vice President, Head of Marketing Strategy for Astellas’ global strategic products, since April 2015 and has over 30 years of diverse and international experience in Astellas. He has also held various positions in marketing, sales operations and strategic planning in Japan, the USA, EMEA and Asia.
Yoshihiko Hatanaka, President and Chief Executive Officer of Astellas Pharma Inc., said: “The appointment of Yukio Matsui as President of EMEA Operations brings more than 30 years experience to the role – including various important positions in all four regions including Japan, Americas, EMEA, and Asia/Oceania. This experience will be crucial in securing the future success of Astellas for all stakeholders.”
Mr Matsui said: “I am delighted and honoured to be assuming the role of President of EMEA Operations. I join at an exciting time with recent launches of a number of innovative medicines and a compelling pipeline in late-stage clinical development for our region. I am confident we will deliver on the Astellas promise of improving the lives of those patients who depend on our medicines.”
Mr Matsui succeeds Mr Jones, who resigned at the end of February.